Volume 10 - پاییز و زمستان86-                   mjms 2008, 10 - پاییز و زمستان86-: 19-30 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rafiee M R, Kalhor H R, Marandi M, Mowla S J. Strategies for Reprogramming of Adult Cells: From Nuclear Transfer to Induction of Pluripotency Using Specific Transcription Factors. mjms. 2008; 10 :19-30
URL: http://mjms.modares.ac.ir/article-30-10182-en.html
1- Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, Tehran, Iran
2- Department of Biochemistry, Faculty of Basic Sciences, Tarbiat Modares University, Tehran, Iran
3- Nanomedicine and Tissue Engineering Research center, Medical University of Shahid Beheshti, Tehran, Iran
4- Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:   (4483 Views)
Clinical application of embryonic stem (ES) cells faces difficulties regarding tissue rejection as well as ethical limitations. One solution for these issues is to reprogram somatic cells by the injection of their nucleus into an enucleated oocyte or zygote. However, technical complications and ethical considerations have impeded the therapeutic implications of this technology. An approach which is most recently developed is in vitro induction of reprogramming in adult cells. This was first achieved by using four transcription factors, including Oct4, Sox2, c-Myc and Klf4. Subsequently, many ongoing efforts were performed for enhancing this method, also for making it compatible with clinical applications. However, there is still a long road ahead. In this paper we review strategies to reprogram somatic cells to embryonic state and discuss about the recent strategy and the relevant developments.
Full-Text [PDF 484 kb]   (5266 Downloads)    

Received: 2007/09/1 | Accepted: 2007/10/9

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.